share_log

中国医药(600056.SH):克林霉素磷酸酯注射液获得药品注册批件

china meheco group (600056.SH): Clindamycin Phosphate Injection Obtained Drug Registration Certificate

Gelonghui Finance ·  Nov 21, 2024 16:44

On November 21, 2023, china meheco group (600056.SH) announced that its wholly-owned subsidiary hainan Tongyong Kangli Pharmaceutical Co., Ltd. received three drug registration certificates for Clindamycin Phosphate Injection approved and issued by the National Medical Products Administration. Clindamycin Phosphate Injection is mainly used for severe infections caused by sensitive anaerobic bacteria, streptococci, pneumococci, staphylococcus sensitive strains and specific microorganisms.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment